Philips Reinforces Its Global Innovation Leadership with Clarivate Top 100 Global Innovator 2026 Award

Amsterdam, Netherlands – Royal has once again proven its position as a world-class innovator by being named a Clarivate Top 100 Global Innovator for the 13th consecutive year. This remarkable achievement highlights Philips’ long-standing commitment to research, development, and intellectual property excellence, reinforcing its role as a global leader in health technology and innovation.

The recognition, announced by , places Philips among an elite group of organizations that consistently demonstrate outstanding innovation performance, robust patent strategies, and significant contributions to technological progress worldwide.

Clarivate Top 100 Global Innovators: A Benchmark for Excellence

The Clarivate Top 100 Global Innovators ranking is widely regarded as one of the most respected benchmarks for measuring innovation excellence. The methodology is based on rigorous analysis of global patent data, evaluating organizations on factors such as influence, success rate, geographic reach, and technological uniqueness.

Philips’ continued presence on this prestigious list for over a decade reflects not only the volume of its inventions but also the quality and real-world impact of its innovations. The company’s intellectual property portfolio plays a critical role in advancing healthcare solutions that improve patient outcomes, enhance clinical workflows, and drive sustainable healthcare systems.

Innovation at the Core of Philips’ Strategy

Innovation has long been embedded in Philips’ corporate DNA. With a history spanning more than 130 years, the company has consistently evolved by investing heavily in research and development. Each year, Philips allocates a significant portion of its revenue to R&D, enabling the creation of cutting-edge technologies across healthcare, diagnostics, imaging, and digital health solutions.

Being recognized as a Clarivate Top 100 Global Innovator for the 13th consecutive year underscores the effectiveness of Philips’ innovation strategy. It also demonstrates how the company aligns technological advancement with meaningful societal impact, particularly in addressing some of the world’s most pressing healthcare challenges.

Strong Intellectual Property Portfolio Driving Global Impact

At the heart of Philips’ innovation success lies its strong and diverse intellectual property (IP) portfolio. The company consistently ranks among the top patent filers in Europe and globally, with thousands of active patents covering areas such as:

• Medical imaging systems
• Patient monitoring technologies
• Artificial intelligence and data analytics
• Connected care and digital health platforms
• Personal health and wellness solutions

This robust IP foundation enables Philips to protect its innovations while fostering collaboration with healthcare providers, research institutions, and technology partners worldwide.

Advancing Healthcare Through Meaningful Innovation

Philips’ innovations are designed with a clear purpose: to improve people’s health and well-being across the entire care continuum. From early diagnosis and precision imaging to treatment guidance and home-based care, Philips leverages technology to deliver better outcomes for patients and clinicians alike.

Key areas where Philips continues to make significant advancements include:

Artificial Intelligence and Data-Driven Healthcare

Philips has been at the forefront of integrating artificial intelligence into healthcare solutions. By embedding AI into imaging, diagnostics, and patient monitoring systems, the company helps clinicians make faster, more accurate decisions while reducing administrative burden.

Connected and Personalized Care

Through connected care platforms, Philips enables seamless data sharing across healthcare environments. This approach supports personalized treatment plans, improves continuity of care, and empowers patients to take an active role in managing their health.

Sustainability and Responsible Innovation

In addition to technological excellence, Philips is committed to sustainability and responsible innovation. The company focuses on designing energy-efficient products, reducing waste, and promoting circular economy principles across its operations and supply chains.

Leadership Perspective on the Achievement

Philips’ leadership has emphasized that this recognition is a testament to the dedication and creativity of its global workforce. Thousands of engineers, scientists, and researchers across the organization contribute daily to developing solutions that address real healthcare needs.

The continued recognition by Clarivate also reinforces Philips’ belief that strong intellectual property protection is essential for fostering innovation, encouraging investment in R&D, and enabling long-term value creation for customers and society.

Global Recognition Reflects Consistency and Long-Term Vision

Being named a Top 100 Global Innovator for 13 consecutive years is a rare and impressive accomplishment. It reflects Philips’ ability to maintain innovation momentum despite rapidly changing technologies, evolving healthcare demands, and global economic challenges.

This consistency is driven by a clear long-term vision that prioritizes:

• Continuous investment in R&D
• Strategic management of intellectual property
• Collaboration with global partners
• Focus on customer and patient needs

Philips’ Role in Shaping the Future of Healthcare

As healthcare systems worldwide face increasing pressure from aging populations, chronic diseases, and resource constraints, innovation has never been more critical. Philips is uniquely positioned to help address these challenges through scalable, technology-driven solutions.

The company’s innovations support healthcare providers in delivering high-quality care more efficiently, while also enabling preventive and home-based care models that reduce the burden on hospitals.

Clarivate’s Methodology Highlights Quality Over Quantity

Clarivate’s Top 100 Global Innovators ranking is not based solely on the number of patents filed. Instead, it evaluates the overall strength and influence of an organization’s innovation output. This includes assessing how often patents are cited, their global reach, and their ability to generate commercial and societal value.

Philips’ repeated recognition demonstrates that its innovations consistently meet these high standards, reinforcing the company’s reputation as a trusted and forward-thinking technology leader.

Looking Ahead: Sustaining Innovation Excellence

Looking to the future, Philips remains committed to pushing the boundaries of healthcare innovation. The company continues to explore emerging technologies such as advanced AI, cloud-based healthcare platforms, and next-generation imaging solutions.

By combining technological expertise with deep clinical insights, Philips aims to create solutions that are not only innovative but also practical, scalable, and impactful in real-world healthcare settings.

Conclusion

The recognition of Philips as a Clarivate Top 100 Global Innovator for the 13th consecutive year is a powerful endorsement of its innovation leadership, intellectual property strength, and long-term commitment to improving global healthcare.

This achievement underscores Philips’ ability to consistently deliver high-quality innovations that make a meaningful difference in people’s lives, while setting a benchmark for excellence in the global innovation landscape.

#PhilipsInnovation #GlobalInnovator #HealthcareTechnology #ClarivateTop100 #SlimScan #GrowthStocks #CANSLIM